Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus

被引：0
|
作者：
Silvija Canecki-Varžić
Ivana Prpić-Križevac
Ines Bilić-Ćurčić
机构：
[1] University Hospital Center Osijek,Department of Diabetes, Endocrinology and Metabolism Disorders
[2] Faculty of Medicine,undefined
[3] University of Osijek,undefined
来源：
BMC Endocrine Disorders | / 16卷
关键词：
Diabetes type 2; Plasminogen activator inhibitor-1; Bone mineral density; Bone turnover markers; Osteoporosis; Osteopenia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus
    Canecki-Varzic, Silvija
    Prpic-Krizevac, Ivana
    Bilic-Curcic, Ines
    [J]. BMC ENDOCRINE DISORDERS, 2016, 16 : 14
  • [2] Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus
    Bayomy, Omar
    Rao, Ajay D.
    Garg, Rajesh
    Vaidya, Anand
    Kotin, Alyssa R.
    Reiber, Beata
    Nijmeijer, Stephanie
    Di Carli, Marcelo F.
    Jerosch-Herold, Michael
    Kwong, Raymond Y.
    Adler, Gail K.
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2017, 15 (06) : 269 - 275
  • [3] American ginseng improves plasminogen activator inhibitor-1 concentrations in type 2 diabetes
    Vuksan, V
    Xu, Z
    Sievenpiper, JL
    Stavro, MP
    Beljan-Zdravkovic, U
    Di Buono, M
    Jenkins, AL
    [J]. DIABETES, 2001, 50 : A368 - A368
  • [4] Increased bone mineral density in postmenopausal women with type 2 diabetes mellitus
    Hadzibegovic, Irzal
    Miskic, Blazenka
    Cosic, Vesna
    Prvulovic, Deiti
    Bistrovic, Dragica
    [J]. ANNALS OF SAUDI MEDICINE, 2008, 28 (02) : 102 - 104
  • [5] Impact of Ethnicity on the Association of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms with Type 2 Diabetes Mellitus
    Al-Hamodi, Z.
    Saif-Ali, R.
    Ismail, I. S.
    Poh, R.
    Ahmed, R. H.
    Muniandy, S.
    [J]. PUBLIC HEALTH GENOMICS, 2015, 18 : 30 - 30
  • [6] Association of fibrinogen and plasminogen activator inhibitor-1 with diabetes mellitus
    Aziz, Iffat Ara
    Fawwad, Asher
    Siddiqui, Iftikhar Ahmed
    Perveen, Kahkashan
    Nangrejo, Ruqaya
    Waris, Nazish
    Basit, Abdul
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 35 (01) : 165 - 169
  • [7] Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus
    Safaei, H.
    Janghorbani, M.
    Aminorroaya, A.
    Amini, M.
    [J]. ACTA DIABETOLOGICA, 2007, 44 (02) : 76 - 82
  • [8] Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus
    H. Safaei
    M. Janghorbani
    A. Aminorroaya
    M. Amini
    [J]. Acta Diabetologica, 2007, 44 : 76 - 82
  • [9] BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES
    Nassar, K.
    Zaher, S.
    Janani, S.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S166 - S167
  • [10] Simvastatin reduces plasma levels of plasminogen activator inhibitor-1 in patients with type 2 diabetes mellitus
    Dharmalingam, S
    Ludwig, S
    Ren, S
    Fenton, JW
    Velthuis, HTE
    Shen, G
    [J]. DIABETES, 2001, 50 : A457 - A457
12345